| |
Average
|
Median
|
Range
|
Standard deviation
|
SEM
|
|---|
|
Age
|
35.8
|
36
|
21-45
|
3.61
|
0.294
|
|
BMI
|
24.5
|
23.5
|
17-41
|
4.78
|
0.74
|
|
Baseline CD3 FSH
|
6.5
|
6
|
2.4-20
|
3.08
|
0.469
|
|
Diagnostic groups
| | | | | | |
|
Late maternal age (>36.9)
|
44.5%
| | | | | |
|
Tubal Factor
|
23.1%
| | | | | |
|
Tubal + Hydroslpings
|
0.0%
| | | | | |
|
Non-Ovulatory
|
1.1%
| | | | | |
|
Male factor
|
56.0%
| | | | | |
|
Endometriosis stage 1 + 2
|
2.2%
| | | | | |
|
Endometriosis stage 3 + 4
|
6.6%
| | | | | |
|
Unexplained
|
8.8%
| | | | | |
|
Repeated pregnancy loss
|
1.1%
| | | | | |
- Characteristics of the patients included in the study. For each parameter we describe, the average, median, range, standard deviation, number of observations and the standard error of the mean.
